Summary: A genetic marker linked to human Restless Legs Syndrome (RLS) is essential for healthy cerebellar development. Researchers found that mutating the MEIS1 gene in zebrafish larvae disrupts their normal rhythmic “burst-and-glide” locomotion and produces prolonged, hyperactive movement cycles.
Neuroimaging and cellular analysis traced the altered behavior to a partial loss of Purkinje cells, the cerebellum’s principal inhibitory neurons that coordinate movement. Medications commonly used to treat human RLS corrected the abnormal locomotion in the mutant fish, providing mechanistic evidence that a known RLS risk gene can impair motor pathways and highlighting the cerebellum as a target for future clinical research.
Key Facts
- Understanding the urge: Restless Legs Syndrome affects millions worldwide, but objective biological markers and clear mechanistic explanations have been limited.
- Altered locomotion: Zebrafish with mutated MEIS1 lose their characteristic “burst-and-glide” swimming pattern and instead display prolonged, continuous movement bursts consistent with hyperactivity.
- Purkinje cell loss: The absence of functional MEIS1 impairs cerebellar development and results in a measurable reduction of Purkinje cells, which normally exert inhibitory control over motor circuits.
- Reduced motor braking: With fewer Purkinje cells, inhibitory control over downstream motor neurons is weakened, allowing motor circuits to over-fire and produce abnormal, persistent movement.
- Drug validation: Standard RLS medications used in clinical practice restored normal locomotor patterns in the mutant zebrafish, supporting the translational relevance of the model.
Source: University of Basel
Restless legs, restless nights: Restless Legs Syndrome (RLS) is a common but still poorly understood sleep disorder. Using larval zebrafish, a team at the University of Basel identified a role for an RLS-associated gene in cerebellar development and motor control, offering new clues into the biology that may underlie RLS symptoms.
RLS produces an irresistible urge to move the legs or other body parts, often accompanied by unpleasant sensations that worsen at night or during periods of rest. Despite its prevalence, the biological causes of RLS are incompletely defined, and diagnosis relies largely on patient-reported symptoms.
The study, led by Professor Alex Schier at the Biozentrum of the University of Basel, used larval zebrafish to probe how RLS-associated genes influence nervous system development and behavior.
“Human studies have implicated several brain regions, but how those findings connect to specific symptoms remains unclear,” says Schier. “Our results emphasize a possible contribution from the cerebellum, a structure central to movement coordination.”
Genes and sleep-related disorders
The project began as a broader effort to link human sleep-disorder risk genes to neuronal and behavioral functions. Previous human genetic studies had flagged several candidate genes for RLS, but their roles within brain circuits were not well defined, explains Dr. William Joo, the study’s first author.
Zebrafish with altered movement patterns
Among the genes tested, MEIS1 stood out. Mutations in this gene led to a clear change in larval zebrafish behavior. Wild-type larvae swim in a distinct “burst-and-glide” pattern—brief bouts of activity followed by pauses. In contrast, MEIS1 mutants showed much longer movement bouts and fewer pauses.
This behavioral shift prompted a detailed search for structural and activity differences in the brain. Imaging and cellular analyses uncovered developmental abnormalities concentrated in the cerebellum of the mutant fish.
The cerebellum in focus
Purkinje cells, a major cerebellar neuron type that provides inhibitory signals (GABAergic) to downstream targets, were notably depleted in MEIS1 mutants. “The partial loss of Purkinje cells alters the balance of cerebellar output,” notes Joo.
Loss of this inhibitory control appears to perturb downstream motor circuits, producing the prolonged, hyperactive locomotion observed in mutant larvae. To test clinical relevance, the researchers treated the mutant fish with medications commonly prescribed for human RLS and observed a restoration of normal movement patterns.
Implications for therapy and diagnosis
This work provides a mechanistic link between an RLS-associated gene, cerebellar development, and motor behavior. The study suggests that other RLS risk genes might similarly affect cerebellar circuits. While zebrafish are an experimental model and human validation is required, the findings point to new avenues for understanding RLS biology, refining diagnosis, and developing targeted treatments.
Further research will need to determine whether similar cerebellar changes occur in people with RLS and how best to leverage these insights for clinical benefit.
Key Questions Answered:
A: Zebrafish share a conserved genetic architecture and basic central nervous system organization with mammals, including similar neurotransmitter systems and primitive sleep–wake networks. Larval zebrafish display a clear, quantifiable “burst-and-glide” locomotor pattern governed by core motor-coordination circuits, making it straightforward to detect subtle, gene-driven changes in movement.
A: Purkinje cells are the cerebellum’s principal output neurons, primarily releasing GABA to inhibit downstream motor pathways. They act like a braking system for movement. When MEIS1 mutation causes a partial loss of Purkinje cells, this inhibitory regulation weakens and motor circuits can become overactive, producing continuous or exaggerated movements consistent with restlessness.
A: The team applied standard, clinically used RLS medications to the MEIS1 mutant zebrafish larvae and observed normalization of their locomotor behavior. This pharmacological rescue supports the idea that the disrupted pathways in the fish overlap with neurochemical mechanisms targeted in human RLS treatment.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by staff.
About this genetics and neurology research news
Author: Angelika Jacobs
Source: University of Basel
Contact: Angelika Jacobs – University of Basel
Image credit: Neuroscience News
Original Research: Open access. “Disinhibition of cerebellar output by loss of Restless Legs Syndrome-associated gene MEIS1” by Joo W, Choi JW, Schier AF. Current Biology
DOI: 10.1016/j.cub.2026.05.043
Abstract
Disinhibition of cerebellar output by loss of Restless Legs Syndrome-associated gene MEIS1
Genome-wide association studies have identified risk variants for restless legs syndrome (RLS), but the behavioral functions and sites of action of the corresponding genes remain unknown.
In this study, zebrafish mutants for candidate RLS genes were analyzed and meis1b was found to be necessary for normal locomotor behavior and cerebellar development.
Neuronal manipulations indicate that loss of meis1b alters locomotion by producing abnormal cerebellar output — a mechanism reminiscent of movement disorders such as ataxia and dystonia.